The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Influence of Interleukin‐1 Receptor Antagonist Gene Polymorphism on Disease
Abstract
Interleukin-1 receptor antagonist (IL-1RA) is a naturally occurring competitive inhibitor of interleukin-1 (IL-1)-induced proinflammatory activity. The IL-1RA gene is polymorphic, resulting in quantitative differences in both IL-1RA and IL-1beta production. Persons homozygous for allele 2 of the IL-1RA gene (IL1RN*2) have a more prolonged and more severe proinflammatory immune response than persons with other IL-1RA genotypes. Thus, being IL1RN*2 homozygous might be beneficial when combating infectious agents or malignantly transformed cells, but it might be detrimental for those with chronic inflammatory conditions or who are pregnant. The IL1RN*2 phenotype is associated with ulcerative colitis and Crohn's disease, lupus erythematosus, vulvar vestibulitis, and possibly with osteoporosis and coronary artery disease. IL1RN*2 homozygosity may also be associated with recurrent spontaneous abortion, preterm birth, and severity of preeclampsia. Conversely, there are negative associations between IL1RN*2 homozygosity and vaginal colonization with mycoplasmas, infection with human cytomegalovirus and Epstein-Barr virus, human immunodeficiency virus proliferation, and the occurrence of ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Dinarello, C. A. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.2.3277884 · Cited by 1,532
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Tarlow, J., Blakemore, A. F., Lennard, A., Solari, R., Hughes, H., Steinkasserer, A., & Duff, G. (1993) · Human Genetics · doi:10.1007/bf00217368 · Cited by 677
Presence of the IL‐1RA Allele 2 (IL1RN*2) is Associated with Enhanced IL‐1β Production In Vitro
Santtila, Savinainen, & Hurme (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00300.x · Cited by 542
Danis, V. A., Millington, M., Hyland, V. J., & Grennan, D. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05549.x · Cited by 530
Hurme, M., & Santtila, S. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199808)28:08<2598::aid-immu2598>3.0.co;2-k · Cited by 430
Mansfield, J. C., Holden, H., Tarlow, J. K., Di Giovine, F. S., McDowell, T. L., Wilson, A. G., Holdsworth, C. D., & Duff, G. W. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90696-3 · Cited by 405
An experimental model for intraamniotic infection and preterm labor in rhesus monkeys
Gravett, M. G., Witkin, S. S., Haluska, G. J., Edwards, J. L., Cook, M. J., & Novy, M. J. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90418-9 · Cited by 336
Self-citationFunctions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.
Hirsch, E., Irikura, V. M., Paul, S. M., & Hirsh, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11008 · Cited by 316
Production of interleukin-1-receptor antagonist during experimental endotoxaemia
Granowitz, E. V., Poutsiaka, D. D., Cannon, J. G., Wolff, S. M., Dinarello, C. A., Santos, A. A., & Wilmore, D. W. (1991) · The Lancet · doi:10.1016/0140-6736(91)92725-h · Cited by 310
Wilkinson, R. J., Patel, P., Llewelyn, M., Hirsch, C. S., Pasvol, G., Snounou, G., Davidson, R. N., & Toossi, Z. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1863 · Cited by 295
McIntyre, K. W., Stepan, G. J., Kolinsky, K. D., Benjamin, W. R., Plocinski, J. M., Kaffka, K. L., Campen, C. A., Chizzonite, R. A., & Kilian, P. L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.931 · Cited by 289
Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.
Kimble, R. B., Vannice, J. L., Bloedow, D. C., Thompson, R. C., Hopfer, W., Kung, V. T., Brownfield, C., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117187 · Cited by 233
Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease
Francis, S. E., Camp, N. J., Dewberry, R. M., Gunn, J., Syrris, P., Carter, N. D., Jeffery, S., Kaski, J. C., Cumberland, D. C., Duff, G. W., et al. (1999) · Circulation · doi:10.1161/01.cir.99.7.861 · Cited by 227
Romero, R., & Tartakovsky, B. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)80035-4 · Cited by 214
Bioque, G., Crusius, J. B. A., Koutroubakis, I., Bouma, G., Kostense, P. J., Meuwissen, S. G. M., & PeÑA, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03793.x · Cited by 203
Tarlow, J. K., Clay, F. E., Cork, M. J., Blakemore, A. I. F., McDonagh, A. J. G., Messenger, A. G., & Duff, G. W. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12395398 · Cited by 196
Andus, T., Daig, R., Vogl, D., Aschenbrenner, E., Lock, G., Hollerbach, S., Kollinger, M., Schölmerich, J., & Gross, V. (1997) · Gut · doi:10.1136/gut.41.5.651 · Cited by 156
Steinkasserer, A., Spurr, N. K., Cox, S., Jeggo, P. A., & Sim, R. B. (1992) · Genomics · doi:10.1016/0888-7543(92)90137-h · Cited by 155
Santos, M. J. D. L., Mercader, A., Francés, A., Portolés, E., Remohi, J. A., Pellicer, A., & Simón, C. (1996) · Biology of Reproduction · doi:10.1095/biolreprod54.3.563 · Cited by 152
Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus
Clay, F. E., Cork, M. J., Tarlow, J. K., et al. (1994) · Human Genetics · doi:10.1007/bf00201602 · Cited by 150
Sunyer, T., Lewis, J., Collin‐Osdoby, P., & Osdoby, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4682 · Cited by 138
Simón, C., Valbuena, D., Krüssel, J.-S., Bernal, A., Murphy, C. R., Shaw, T., Pellicer, A., & Polan, M. L. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00275-1 · Cited by 130
The natural interleukin-1 receptor antagonist in tem and preterm parturition
Romero, R. J., Sepúlveda, W., Mazor, M., Brandt, F., Cotton, D. B., Dinarello, C. A., & Mitchell, M. D. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)80003-2 · Cited by 129
Lynch, E. A., Dinarello, C. A., & Cannon, J. G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.1.300 · Cited by 123
Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis
Jeremias, J., Ledger, W. J., & Witkin, S. S. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70212-2 · Cited by 122
Self-citationKastrati, A., Koch, W., Berger, P. B., Mehilli, J., Stephenson, K. E., Neumann, F.-J., von Beckerath, N., Böttiger, C., Duff, G. W., & Schömig, A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01014-7 · Cited by 121
Langdahl, B. L., Løkke, E., Carstens, M., Stenkjær, L. L., & Eriksen, E. F. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.402 · Cited by 109
Circulating cytokine levels in osteoporotic and normal women
Khosla, S., Peterson, J. M., Egan, K. S., Jones, J. D., & Riggs, B. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.3.8077350 · Cited by 99
Keen, R. W., Woodford-Richens, K. L., Lanchbury, J. S., & Spector, T. D. (1998) · Bone · doi:10.1016/s8756-3282(98)00109-4 · Cited by 97
Abrahamsen, B., Bonnevie‐Nielsen, V., Ebbesen, E. N., Gram, J., & Beck‐Nielsen, H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1545 · Cited by 89
Cytokine Antagonists in Aged Subjects and Their Relation With Cellular Immunity
Catania, A. P., Airaghi, L., Motta, P., Manfredi, M. G., Annoni, G., Pettenati, C., Brambilla, F., & Lipton, J. M. (1997) · The Journals of Gerontology Series A · doi:10.1093/gerona/52a.2.b93 · Cited by 85
Rider, L. G., Artlett, C. M., Foster, C. B., Ahmed, A., Neeman, T. M., Chanock, S. J., Jiménez, S. A., Miller, F. W., & FOR THE CHILDHOOD MYOSITIS HETEROGENEITY COLLABORATIVE STUDY GROUP (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01266.x · Cited by 83
Tarlow, J. K., Cork, M. J., Clay, F. E., et al. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb08779.x · Cited by 75
Immunologic aspects of osteoporosis
Ershler, W. B., Harman, S. M., & Keller, E. T. (1997) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(97)00029-3 · Cited by 65
Barkhuizen, M., Mwantembe, O., Pillay, V., Berry, S. D., Dewar, J. B., Song, E., & Gaillard, M. C. (2001) · Immunogenetics · doi:10.1007/s002510000265 · Cited by 58
Witkin, S. S., Gravett, M. G., Haluska, G. J., et al. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90419-7 · Cited by 56
Self-citationPolymorphisms within the interleukin-1$beta; gene cluster and preeclampsia*1
Hefler, L. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01128-0 · Cited by 52
Treatment of rheumatoid arthritis with IL-1 inhibitors
Gabay, C., & Arend, W. P. (1998) · Springer Seminars in Immunopathology · doi:10.1007/bf00832009 · Cited by 49
Hurme, M., & Helminen (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00406.x · Cited by 48
Hurme, M. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850161403 · Cited by 46
Bry, K., Lappalainen, U., Waffarn, F., Teramo, K., & Hallman, M. (1994) · Pediatric Research · doi:10.1203/00006450-199401000-00029 · Cited by 37
Bajnok, É., Takács, I., Vargha, P., et al. (2000) · Bone · doi:10.1016/s8756-3282(00)00360-4 · Cited by 29
Witkin, S. S., Linhares, I. M., Gerber, S., Caetano, M. E., & Segurado, A. A. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6242-6244.2001 · Cited by 19
Self-citation
Cited by
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
The Role of Inflammation and Infection in Preterm Birth
Romero, R., Espinoza, J., Gonçalves, L., Kusanovic, J., Friel, L., & Hassan, S. (2007) · Seminars in Reproductive Medicine · doi:10.1055/s-2006-956773 · Cited by 897
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
The Fetal Inflammatory Response Syndrome
GOTSCH, F., ROMERO, R., KUSANOVIC, J. P., MAZAKI-TOVI, S., PINELES, B. L., EREZ, O., ESPINOZA, J., & HASSAN, S. S. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31811ebef6 · Cited by 515
Targeting Interleukin-1 in Heart Disease
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013) · Circulation · doi:10.1161/circulationaha.113.003199 · Cited by 302
Metadata
- Authors
- Witkin, S. S., Gerber, S., & Ledger, W. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-01-15
- Volume
- 34
- Issue
- 2
- Pages
- 204-209
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2170963398
- Cited by
- 301
- References
- 46
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.